Skip to main content
Premium Trial:

Request an Annual Quote

Nasdaq Grants Pressure Bio Extension to Regain Compliance

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pressure BioSciences today said that it has received notification from Nasdaq that the firm has been granted an extension until Oct. 3, 2011, to regain compliance with the exchange's minimum stockholders' equity requirement of $2.5 million.

The South Easton, Mass.-based firm received the staff deficiency letter from Nasdaq in early April saying that it was not incompliance with the rule. It submitted a written plan to Nasdaq on May 23, outlining its strategy to regain compliance. In that plan, Pressure Bio said that it would need to raise at least $5 million in additional equity capital to report stockholders' equity of more than $2.5 million.

Nasdaq notified the firm on June 10 that it has until Oct. 3, 2011, to regain compliance.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.